Company intelligence / Profile preview

Medipharm Sweden

Kågeröd, Skåne, Sweden

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Medipharm Sweden is a biotechnology company specializing in the development and production of probiotics for human and animal health applications. Established in 1982, the company was a pioneer in the application of lactic acid bacteria for silage preservation and animal nutrition. Following its acquisition by Chr. Hansen in 2008, Medipharm's operations were integrated into a global bioscience framework, focusing on high-quality microbial solutions. The company's facility in Kågeröd remains a significant center for fermentation technology and the production of probiotic cultures within the Novonesis group.

Therapeutic areas: OtherGastroenterology
Modalities: Live biotherapeutic product therapyMicrobial therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Medipharm Sweden.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medipharm Sweden.

Explore the full profile